Lunai Bioworks Receives Nasdaq Notice for Market Value Noncompliance

Reuters10-30
<a href="https://laohu8.com/S/LNAI">Lunai Bioworks</a> Receives Nasdaq Notice for Market Value Noncompliance

Lunai Bioworks Inc. has announced that it received a notification from the Nasdaq Stock Market indicating the company is not in compliance with the $35 million minimum Market Value of Listed Securities (MVLS) requirement. This notice follows 30 consecutive business days during which Lunai Bioworks' MVLS remained below the required threshold. The company has 180 calendar days, until April 27, 2026, to regain compliance by maintaining an MVLS of at least $35 million for a minimum of 10 consecutive business days. Lunai Bioworks' common stock will continue to trade under the symbol "LNAI" during this period. If compliance is not regained, the company may face delisting but will have the opportunity to appeal the decision.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lunai Bioworks Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001731122-25-001446), on October 30, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment